Viewing Study NCT05918861


Ignite Creation Date: 2025-12-24 @ 1:03 PM
Ignite Modification Date: 2026-02-02 @ 8:34 PM
Study NCT ID: NCT05918861
Status: RECRUITING
Last Update Posted: 2025-08-08
First Post: 2023-06-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Sponsor: DalCor Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module